Hyperion Therapeutics To Report First Quarter 2013 Financial Results After Market On May 9, 2013

SOUTH SAN FRANCISCO, Calif., May 6, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report financial results for the first quarter 2013 ended March 31, 2013, after market closes on Thursday, May 9, 2013. Hyperion will host a webcast and conference call with management to discuss financial results, as well as provide a general corporate update, at 4:30 p.m. EDT (1:30 p.m. PDT).

A live audio webcast of the conference call can be accessed on Hyperion's investor relations website at: http://investors.hyperiontx.com/events.cfm

To access the live conference call, dial 877-847-7188 U.S. or 408-427-3787 International and use the conference ID# 46599927. A replay of the call will be available for 30 days by accessing Hyperion's investor relations website or by dialing 855-859-2056 U.S. or (404) 537-3406 International and use conference ID# 46599927 beginning approximately one hour after the conference call concludes.

About Hyperion Therapeutics

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases and hepatology.
CONTACT: Myesha Edwards, Investor Relations         (650) 745-7829         sannes@annesassociates.com                  Kristie Kuhl, Media Relations         (203) 556-7417         kkuhl@makovsky.com

If you liked this article you might like

Ireland’s Horizon Pharma Makes $3 Billion Hostile Bid for Depomed

Big Pharma Merger Monday Deals Disregard Biotech Bubble Talks

Stock Markets Soar on Trifecta of Good News

Energy Sector Leads Stock Markets Higher as Rally Rolls On

Teva Buys Tourette Syndrome Drug Firm Auspex for $3.2 Billion